COVID-19
New trial exhibits in Doe v. Ladapo: DOH worked with Genspect leaders Stella O’Malley and Joe Burgo in July 2022; Hilary Cass met SEGM’s Patrick Hunter to discuss Florida’s anti-trans report; Jamie Reed’s attorney Vernadette Broyles chose the lineup of detransitioners speaking at the Board of Medicine
Doe v. Ladapo is the case brought by transgender plaintiffs in Florida challenging SB 254, a law prohibiting gender-affirming medical…
What happened, proxalutamide? New antiandrogen for COVID-19 is entangled in clinical data irregularities and human rights violations
Disclaimer: I am not a medical professional and this is not medical advice. From the outset of the COVID-19 pandemic,…
Trans Broken Brain Syndrome: When “subjective cognitive decline” becomes a subjective attack on trans healthcare
By Heather McNamara Have you ever looked at an object and forgotten what it was called? Maybe you’ve been in…
Zinnia’s college adventures, year 3: A Florida public university is forcing us into conditions of unchecked pandemic exposure
Previously: Zinnia goes to college, gets more knowledge (June 2019) Zinnia’s continued college adventures: summer 2019 (August 2019) Notes on…
AstraZeneca or not, cerebral venous sinus thrombosis is a complex and potentially fatal emergency. Is the world prepared?
Disclaimer: I am not a medical professional and this is not medical advice. The COVID-19 pandemic and investigations into the…
Proxalutamide, a new antiandrogen, improves COVID-19 outcomes in trials of men and women
Previously: COVID-19 updates: From spironolactone to estrogen to GnRH antagonists (May 2020) Disclaimer: I am not a medical professional and…
2020’s hard lessons in public health pessimism
I was wrong. For the better part of a decade, my approach to communicating transgender medicine and science to the…
June COVID-19 update: Reassuring data on spironolactone and ACE2 risks
Disclaimer: I am not a medical professional and this is not medical advice. Our understanding of the pandemic is evolving…
May COVID-19 updates: From spironolactone to estrogen to GnRH antagonists
Disclaimer: I am not a medical professional and this is not medical advice. Our understanding of the pandemic is evolving…
The American Enterprise Institute’s statistical fumbles: Misusing linear regression for short-term COVID-19 trends
Disclaimer: I am not a medical professional, an expert in statistics or epidemiology, or a former FDA commissioner. Since the…